India's drug regulator cancelled seven Ethics Committee registrations nationwide. Inspections revealed serious violations of clinical trial rules and guidelines. These committees oversee participant rights and safety during medical studies. The action followed a thorough compliance assessment and review process. This move ensures better adherence to regulatory standards for drug trials. Read more